Stockscreener 앱 받기
122.84
0.24%
-0.29
시간 외 거래:
122.72
-0.12
-0.10%
전일 마감가:
$123.13
열려 있는:
$123.405
하루 거래량:
7.23M
Relative Volume:
0.68
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.66%
1개월 성능:
+7.74%
6개월 성능:
+46.94%
1년 성능:
+31.52%
1일 변동 폭
$122.22
$124.53
1주일 범위
$120.66
$124.53
52주 변동 폭
$66.66
$125.87
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
XBI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
122.84 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.33 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
680.73 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.15 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
261.24 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
610.54 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf 주식(XBI)의 최신 뉴스
I'm Eyeing One Big, One Little Biotech for a Repeat Trade - TheStreet Pro
Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock - AOL.com
2 Brilliant Biotech ETFs to Watch in 2026 - AOL.com
Biotech ETFs Gain Momentum with Promising Gains and Risks - cointurk finance
Eight stock picks to play one of the healthiest corners of the market - MarketWatch
Opinion: The Fed cut rates. Biotech didn’t notice. - MarketWatch
Biotech ETF (XBI) Hits New 52-Week High - TradingView
The Biotech Industry Is Healthier Than Investors Think. The Stocks to Watch. - Barron's
Meet the New AI Winners: Alphabet, Tesla and Even Big Pharma and Biotech - Barron's
1 Sector ETF to Avoid Like the Plague in November - AOL.com
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - sharewise.com
ETFs Investing in ArriVent BioPharma, Inc. Stocks - TradingView
Gold Miners Are Crushing Gold: UBS Says Grab These 5 Cheap Picks - AOL.com
IYK vs. XLP: Top Holdings Could Make the Difference - AOL.com
State Street SPDR and iShares ETFs Deliver Strong Growth Without AI Stocks - cointurk finance
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - sharewise.com
This Fund Leaned Into 2025's Big Biotech Rally with a $9.5 Million Bet on Mineralys - AOL.com
Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year - AOL.com
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Apple, Taiwan Semiconductor Manufacturing And More On CNBC's 'Final Trades' - Benzinga
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI - sharewise.com
Best-Performing ETFs of Last Week: Healthcare Rules - sharewise.com
Why biotech and drug stocks are on the mend even though the rest of the market is hurting - MSN
3 Biotech Stocks Wall Street Analysts Predict Will More Than Double - MSN
ETFs Investing in Janux Therapeutics, Inc. Stocks - TradingView
S&P 500: Health Care Stocks Come Alive — Nudging Tech Aside For Now - Investor's Business Daily
Biotech Stock Gets Booted in Latest Fund Update - AOL.com
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - sharewise.com
(11/19/25) PFE: The Winner in the Metsera Bidding War - moneyshow.com
Why biotech and drug stocks are rallying even though the rest of the market is hurting - MSN
M&A Injects Life Into Biotech Trade - TheStreet Pro
XBI: Biotech Funding Condition Recovery Could Be Overdue (NYSEARCA:XBI) - Seeking Alpha
XBI: An Equal Weight ETF On Biotech That Amplifies Its Speculative Component - Seeking Alpha
Breakthrough bets on life sciences rebound with $430m fundraise - Private Equity Real Estate | PERE
This Biotech Stock Soared 100%. Merck Is Buying It. - Barron's
META_TITLE_SECTORS - Yahoo Finance
Money Moving Into Healthcare Not AI; Four Fed Presidents Do Not Want a Rate Cut; Euphoria Wearing Off - Sahm
Two Biotech Stocks to Watch as Sector Bounces Back - TheStreet Pro
2 Aggressive Growth ETFs That Can Beat the Market - AOL.com
Should You Invest in the State Street SPDR S&P Semiconductor ETF (XSD)? - Yahoo Finance
Should You Invest in the State Street SPDR S&P Oil & Gas Exploration & Production ETF (XOP)? - Nasdaq
State Street Spdr S P Biotech Etf (XBI) 재무 분석
State Street Spdr S P Biotech Etf (XBI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.38%
0.49%
자본화:
|
볼륨(24시간):